Delaney William E IV 4
4 · ASSEMBLY BIOSCIENCES, INC. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Delaney William E IV
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-16+10,000→ 88,919 total
Footnotes (2)
- [F1]Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.
- [F2]Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.